Aurora kinase A is a target of Wnt/β-catenin involved in multiple myeloma disease progression

Jui Dutta-Simmons, Yunyu Zhang, Gullu Gorgun, Moshe Gatt, Mala Mani, Teru Hideshima, Kohichi Takada, Nicole E. Carlson, Daniel E. Carrasco, Yu Tzu Tai, Noopur Raje, Anthony G. Letai, Kenneth C. Anderson, Daniel R. Carrasco

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Multiple myeloma (MM) is a cancer of plasma cells with complex molecular characteristics that evolves from monoclonal gammopathy of undetermined significance, a highly prevalent premalignant condition. MM is the second most frequent hematologic cancer in the United States, and it remains incurable, thereby highlighting the need for new therapeutic approaches, particularly those targeting common molecular pathways involved in disease progression and maintenance, shared across different MM subtypes. Here we report that Wnt/β-catenin is one such pathway. We document the involvement of β-catenin in cell-cycle regulation, proliferation, and invasion contributing to enhanced proliferative and metastatic properties of MM. The pleiotropic effects of β-catenin in MM correlate with its transcriptional function, and we demonstrate regulation of a novel target gene, Aurora kinase A, implicating β-catenin in G2/M regulation. β-catenin and Aurora kinaseA are present in most MM but not in normal plasma cells and are expressed in a pattern that parallels progression from monoclonal gammopathy of undetermined significance to MM. Our data provide evidence for a novel functional link between β-catenin and Aurora kinase A, underscoring a critical role of these pathways in MM disease progression.

Original languageEnglish (US)
Pages (from-to)2699-2708
Number of pages10
JournalBlood
Volume114
Issue number13
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Aurora Kinase A
Catenins
Multiple Myeloma
Disease Progression
Monoclonal Gammopathy of Undetermined Significance
Plasma Cells
Plasmas
Critical Pathways
Genes
Cells
Neoplasms
Cell Cycle
Maintenance

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Dutta-Simmons, J., Zhang, Y., Gorgun, G., Gatt, M., Mani, M., Hideshima, T., ... Carrasco, D. R. (2009). Aurora kinase A is a target of Wnt/β-catenin involved in multiple myeloma disease progression. Blood, 114(13), 2699-2708. https://doi.org/10.1182/blood-2008-12-194290

Aurora kinase A is a target of Wnt/β-catenin involved in multiple myeloma disease progression. / Dutta-Simmons, Jui; Zhang, Yunyu; Gorgun, Gullu; Gatt, Moshe; Mani, Mala; Hideshima, Teru; Takada, Kohichi; Carlson, Nicole E.; Carrasco, Daniel E.; Tai, Yu Tzu; Raje, Noopur; Letai, Anthony G.; Anderson, Kenneth C.; Carrasco, Daniel R.

In: Blood, Vol. 114, No. 13, 2009, p. 2699-2708.

Research output: Contribution to journalArticle

Dutta-Simmons, J, Zhang, Y, Gorgun, G, Gatt, M, Mani, M, Hideshima, T, Takada, K, Carlson, NE, Carrasco, DE, Tai, YT, Raje, N, Letai, AG, Anderson, KC & Carrasco, DR 2009, 'Aurora kinase A is a target of Wnt/β-catenin involved in multiple myeloma disease progression', Blood, vol. 114, no. 13, pp. 2699-2708. https://doi.org/10.1182/blood-2008-12-194290
Dutta-Simmons J, Zhang Y, Gorgun G, Gatt M, Mani M, Hideshima T et al. Aurora kinase A is a target of Wnt/β-catenin involved in multiple myeloma disease progression. Blood. 2009;114(13):2699-2708. https://doi.org/10.1182/blood-2008-12-194290
Dutta-Simmons, Jui ; Zhang, Yunyu ; Gorgun, Gullu ; Gatt, Moshe ; Mani, Mala ; Hideshima, Teru ; Takada, Kohichi ; Carlson, Nicole E. ; Carrasco, Daniel E. ; Tai, Yu Tzu ; Raje, Noopur ; Letai, Anthony G. ; Anderson, Kenneth C. ; Carrasco, Daniel R. / Aurora kinase A is a target of Wnt/β-catenin involved in multiple myeloma disease progression. In: Blood. 2009 ; Vol. 114, No. 13. pp. 2699-2708.
@article{a9e47059dffa453cbb51fb8ddc8ec30f,
title = "Aurora kinase A is a target of Wnt/β-catenin involved in multiple myeloma disease progression",
abstract = "Multiple myeloma (MM) is a cancer of plasma cells with complex molecular characteristics that evolves from monoclonal gammopathy of undetermined significance, a highly prevalent premalignant condition. MM is the second most frequent hematologic cancer in the United States, and it remains incurable, thereby highlighting the need for new therapeutic approaches, particularly those targeting common molecular pathways involved in disease progression and maintenance, shared across different MM subtypes. Here we report that Wnt/β-catenin is one such pathway. We document the involvement of β-catenin in cell-cycle regulation, proliferation, and invasion contributing to enhanced proliferative and metastatic properties of MM. The pleiotropic effects of β-catenin in MM correlate with its transcriptional function, and we demonstrate regulation of a novel target gene, Aurora kinase A, implicating β-catenin in G2/M regulation. β-catenin and Aurora kinaseA are present in most MM but not in normal plasma cells and are expressed in a pattern that parallels progression from monoclonal gammopathy of undetermined significance to MM. Our data provide evidence for a novel functional link between β-catenin and Aurora kinase A, underscoring a critical role of these pathways in MM disease progression.",
author = "Jui Dutta-Simmons and Yunyu Zhang and Gullu Gorgun and Moshe Gatt and Mala Mani and Teru Hideshima and Kohichi Takada and Carlson, {Nicole E.} and Carrasco, {Daniel E.} and Tai, {Yu Tzu} and Noopur Raje and Letai, {Anthony G.} and Anderson, {Kenneth C.} and Carrasco, {Daniel R.}",
year = "2009",
doi = "10.1182/blood-2008-12-194290",
language = "English (US)",
volume = "114",
pages = "2699--2708",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "13",

}

TY - JOUR

T1 - Aurora kinase A is a target of Wnt/β-catenin involved in multiple myeloma disease progression

AU - Dutta-Simmons, Jui

AU - Zhang, Yunyu

AU - Gorgun, Gullu

AU - Gatt, Moshe

AU - Mani, Mala

AU - Hideshima, Teru

AU - Takada, Kohichi

AU - Carlson, Nicole E.

AU - Carrasco, Daniel E.

AU - Tai, Yu Tzu

AU - Raje, Noopur

AU - Letai, Anthony G.

AU - Anderson, Kenneth C.

AU - Carrasco, Daniel R.

PY - 2009

Y1 - 2009

N2 - Multiple myeloma (MM) is a cancer of plasma cells with complex molecular characteristics that evolves from monoclonal gammopathy of undetermined significance, a highly prevalent premalignant condition. MM is the second most frequent hematologic cancer in the United States, and it remains incurable, thereby highlighting the need for new therapeutic approaches, particularly those targeting common molecular pathways involved in disease progression and maintenance, shared across different MM subtypes. Here we report that Wnt/β-catenin is one such pathway. We document the involvement of β-catenin in cell-cycle regulation, proliferation, and invasion contributing to enhanced proliferative and metastatic properties of MM. The pleiotropic effects of β-catenin in MM correlate with its transcriptional function, and we demonstrate regulation of a novel target gene, Aurora kinase A, implicating β-catenin in G2/M regulation. β-catenin and Aurora kinaseA are present in most MM but not in normal plasma cells and are expressed in a pattern that parallels progression from monoclonal gammopathy of undetermined significance to MM. Our data provide evidence for a novel functional link between β-catenin and Aurora kinase A, underscoring a critical role of these pathways in MM disease progression.

AB - Multiple myeloma (MM) is a cancer of plasma cells with complex molecular characteristics that evolves from monoclonal gammopathy of undetermined significance, a highly prevalent premalignant condition. MM is the second most frequent hematologic cancer in the United States, and it remains incurable, thereby highlighting the need for new therapeutic approaches, particularly those targeting common molecular pathways involved in disease progression and maintenance, shared across different MM subtypes. Here we report that Wnt/β-catenin is one such pathway. We document the involvement of β-catenin in cell-cycle regulation, proliferation, and invasion contributing to enhanced proliferative and metastatic properties of MM. The pleiotropic effects of β-catenin in MM correlate with its transcriptional function, and we demonstrate regulation of a novel target gene, Aurora kinase A, implicating β-catenin in G2/M regulation. β-catenin and Aurora kinaseA are present in most MM but not in normal plasma cells and are expressed in a pattern that parallels progression from monoclonal gammopathy of undetermined significance to MM. Our data provide evidence for a novel functional link between β-catenin and Aurora kinase A, underscoring a critical role of these pathways in MM disease progression.

UR - http://www.scopus.com/inward/record.url?scp=70350492327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350492327&partnerID=8YFLogxK

U2 - 10.1182/blood-2008-12-194290

DO - 10.1182/blood-2008-12-194290

M3 - Article

C2 - 19652203

AN - SCOPUS:70350492327

VL - 114

SP - 2699

EP - 2708

JO - Blood

JF - Blood

SN - 0006-4971

IS - 13

ER -